Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma

Not Applicable

Completed

• Conditions: Hepatocellular Carcinomas; Hepatitis
• Interventions: Device: Low intensity amplitude-moduled electromagnetic fields

• Registration Number: NCT01641276
• Lead Sponsor: Hospital Sirio-Libanes

Brief Summary

The propose of this study is to identification of a group of specific amplitude-modulated frequencies of low intensity electromagnetic fields that is associated with biofeedback upon exposure to in patients with hepatitis B carries with or without hepatocellular carcinoma.

Detailed Description

Patients will be exposed by different specific amplitude-modulated frequencies of low intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be recorded in order to identify biofeedback response. Differences in group of frequencies is expected in patients with hepatitis B carries with or without hepatocellular carcinoma.

Study Timeline

• Study Start: 2012-04
• Study First Submitted: 2012-07-12
• Study First Submitted QC: 2012-07-13
• Study First Posted: 2012-07-16
• Status Verified: 2015-06
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Last Update Submitted: 2015-09-10
• Last Update Posted: 2015-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• hepatitis B carriers patients
• hepatitis B carriers patients with hepatocellular cancer patients

Exclusion Criteria

• other tumor types
• other hepatitis types

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
hepatocellular carcinoma patients	Low intensity amplitude-moduled electromagnetic fields	hepatites B carriers patients with associated hepatocellular carcinoma
hepatitis	Low intensity amplitude-moduled electromagnetic fields	hepatitis B carriers patients

Primary Outcome Measures

Name	Time	Method
Identification of different group of specific frequencies of modulation in hepatitis B carriers with and without hepatocellular carcinoma associated with biofeedback response	within 10 min of exposure	biofeedback response will be monitored

Secondary Outcome Measures

Name	Time	Method
Characterization of differences biofeedback response in hepatitis B carriers with and without hepatocellular carcinoma	within 10 minutes of exposure	Representation of autonomous response during the exposure of specific frequencies of modulation

Trial Locations

Locations (1)

Hospital Sírio Libanês; 🇧🇷 São Paulo, Brazil